Pulmed Pharma's Seed Round

Pulmed Pharma raised a round of funding on , . Investors include Delian Capital.

Hangzhou Changxi, dba Pulmed Pharma, is developing drugs such as generic drugs for alleviating chronic obstructive pulmonary disease and improved drugs for treating asthma.…

Articles about Pulmed Pharma's Seed Round: